← Eichor
Condition: Severe Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Severe Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outco
Phase N/A · 2 location(s) · Artcline GmbH · NCT06143137Treating Severe Mitral Valve Annular or Valvular Calcification Using Shockwave Balloon SMARTWAVE
NA · 1 location(s) · Prince of Wales Hospital, Shatin, Hong Kong · NCT06952374Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
Phase N/A · 1 location(s) · Brigham and Women's Hospital · NCT01177618Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06659588Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections at Risk of Fungal Infection
Phase N/A · 1 location(s) · Central Hospital, Nancy, France · NCT07130799Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functi
NA · 1 location(s) · University of Washington · NCT06710418Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Phase 1 · 2 location(s) · Shionogi · NCT07093580Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis
NA · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT07286643Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
Phase N/A · 3 location(s) · Amsterdam University Medical Centers (UMC), Location Academi · NCT06178822Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05233605PK/PD of Caspofungin in Children Severe Infection
Phase N/A · 2 location(s) · Children's Hospital of Fudan University · NCT04961593Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidn
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT03547414The Role of Obesity in Severe COVID-19 Pathophysiology
NA · 1 location(s) · Franciscus Gasthuis · NCT06968442A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Phase 3 · 148 location(s) · Pfizer · NCT07013474Oropharyngeal Candidiasis (OPC) and S-ECC
Phase N/A · 1 location(s) · Temple University · NCT05761197Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05026138Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis
Phase N/A · 2 location(s) · Qianfoshan Hospital · NCT07530770An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
Phase 3 · 4 location(s) · Novartis Pharmaceuticals · NCT07665437Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Beva
Phase 3 · 32 location(s) · Genelux Corporation · NCT05281471A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
Phase N/A · 25 location(s) · Takeda · NCT06243731A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Ge
Phase N/A · 1 location(s) · Pfizer · NCT05890612Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotyp
Phase 3 · 26 location(s) · Nantes University Hospital · NCT06269900CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
Phase 1 · 7 location(s) · British Columbia Cancer Agency · NCT06208735Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis S
Phase 2 · 30 location(s) · Incyte Corporation · NCT07213973Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Phase 1 · 7 location(s) · AIDS Malignancy Consortium · NCT05077527Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT04712539Real-world Effectiveness, Safety and Immunogenicity of Chikungunya Vaccination in Populations at Risk of Severe or Compl
Phase 4 · 1 location(s) · Centre Hospitalier Universitaire de la Réunion · NCT06928753Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT01371630Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn Injuries
Phase 4 · 1 location(s) · University of Tennessee · NCT07465432
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.